NCT/Study#
N/A /
2021-0512
Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy
DISEASE GROUP:
Lymphoma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
